Basti treatment improved faecal calprotectin and faecal elastase of a patient of inflammatory bowel disease with sarcoidosis - a case report

巴斯蒂疗法改善了一名患有炎症性肠病合并结节病患者的粪便钙卫蛋白和粪便弹性蛋白酶水平——病例报告

阅读:1

Abstract

Inflammatory Bowel Disease (IBD) and sarcoidosis are both chronic inflammatory disorders which in some rare instance can co-exist. The treatment with conventional medicines such as sulfasalazine, mesalamine, and steroids is challenge to patients and may not alleviate the disease completely. Ayurvedic treatments in this regard are often revolutionary and help in compressive management of all symptoms. We present a report of a 40-year-old male with IBD, diagnosed with sarcoidosis having abdominal pain, diarrhoea, and significant weight loss. Dadimadi Ghrita, Matra Basti and modified Piccha Basti were the line of treatment aimed at treating gastrointestinal inflammation and restoring normal bowel functions. The treatments improved the imbalance of Vata and Pitta doshas, that can effectively treat Pittadhik Vata Grahani. The effects of treatment was analysed by stool examination, weight gain and biomarkers useful to assess gastrointestinal health and disease (faecal calprotectin and faecal elastase).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。